![Richard Mason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Mason
Amministratore Delegato presso
Phoqus Pharmaceuticals Plc
Profilo
Richard Mason is currently Chief Executive Officer at Phoqus Pharmaceuticals Plc, Chief Executive Officer & Director at Apollo Therapeutics Group Ltd., and a Member of The Royal College of Physicians.
Former roles include Chief Executive Officer at 4-Antibody AG, Chief Executive Officer & Director at Apollo Therapeutics No.
2 LLP, SVP-Business Development & Commercial Operations at MedImmune Ltd., and Head-Business Development at BTG Ltd. Education includes an MBA from the University of Cambridge and undergraduate studies at University College London.
Posizioni attive di Richard Mason
| Società | Posizione | Inizio |
|---|---|---|
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Amministratore Delegato | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Apollo Therapeutics Group Ltd.
 Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Amministratore Delegato | - |
Precedenti posizioni note di Richard Mason
| Società | Posizione | Fine |
|---|---|---|
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Amministratore Delegato | - |
| BTG | Corporate Officer/Principal | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Presidente | - |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Corporate Officer/Principal | - |
Formazione di Richard Mason
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
99
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Health Technology |
